Page last updated: 2024-10-27

fluoxetine and Epistaxis

fluoxetine has been researched along with Epistaxis in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Epistaxis: Bleeding from the nose.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mowla, A1
Dastgheib, SA1
Ebrahimi, AA1
Pani, A1
Gunzberger, DW1
Martinez, D1

Other Studies

2 other studies available for fluoxetine and Epistaxis

ArticleYear
Nasal bleeding associated with fluoxetine and risperidone interaction: a case report.
    Pharmacopsychiatry, 2009, Volume: 42, Issue:5

    Topics: Depression; Drug Interactions; Epistaxis; Fluoxetine; Follow-Up Studies; Humans; Male; Risperidone;

2009
Adverse vascular effects associated with fluoxetine.
    The American journal of psychiatry, 1992, Volume: 149, Issue:12

    Topics: Adult; Depressive Disorder; Ecchymosis; Epistaxis; Fluoxetine; Hemorrhage; Humans; Male; Obsessive-C

1992